SRT3

178.35

-1%↓

ORNBV.FI

71.3

+0.49%↑

ROVI.ES

53.1

-0.28%↓

OPM.FR

12.9

+0.08%↑

GLPG

28.84

+0.7%↑

SRT3

178.35

-1%↓

ORNBV.FI

71.3

+0.49%↑

ROVI.ES

53.1

-0.28%↓

OPM.FR

12.9

+0.08%↑

GLPG

28.84

+0.7%↑

SRT3

178.35

-1%↓

ORNBV.FI

71.3

+0.49%↑

ROVI.ES

53.1

-0.28%↓

OPM.FR

12.9

+0.08%↑

GLPG

28.84

+0.7%↑

SRT3

178.35

-1%↓

ORNBV.FI

71.3

+0.49%↑

ROVI.ES

53.1

-0.28%↓

OPM.FR

12.9

+0.08%↑

GLPG

28.84

+0.7%↑

SRT3

178.35

-1%↓

ORNBV.FI

71.3

+0.49%↑

ROVI.ES

53.1

-0.28%↓

OPM.FR

12.9

+0.08%↑

GLPG

28.84

+0.7%↑

Search

Pluxee France SA

Chiusa

17.36 0.7

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

16.91

Massimo

17.44

Raccomandazioni

By TipRanks

Raccomandazioni

Neutrale

Previsioni per 12 mesi

+41.58% upside

Dividendi

By Dow Jones

Utili prossimi

30 ott 2025

Pluxee France SA Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

4 ago 2025, 21:42 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Cabot to Acquire Mexico Carbon Manufacturing From Bridgestone

4 ago 2025, 21:21 UTC

Utili
I principali Market Mover

Vertex Stock Falls After Pain-Drug Setback, Despite Stronger 2Q Earnings -- Update

4 ago 2025, 20:45 UTC

Utili

Vertex Pharmaceuticals Swings to 2Q Profit as Sales Climb

4 ago 2025, 19:15 UTC

I principali Market Mover

TransMedics Group Shares Rise on FDA Approval for Clinical Trial

4 ago 2025, 23:41 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

4 ago 2025, 23:41 UTC

Discorsi di Mercato

Nikkei May Rise on Fed Stimulus Hopes

4 ago 2025, 23:28 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

4 ago 2025, 23:28 UTC

Discorsi di Mercato

Gold Seen Stuck in Range as Investors Await Fed's Next Move -- Market Talk

4 ago 2025, 21:30 UTC

Utili

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4 ago 2025, 21:21 UTC

Utili
Acquisizioni, Fusioni, Takeovers

Berkshire Stock Was Hammered Monday. It's Like 1999 Again. -- Barrons.com

4 ago 2025, 21:18 UTC

Utili

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4 ago 2025, 20:25 UTC

Discorsi di Mercato

India Hits Back Over Russian Oil Purchases -- Market Talk

4 ago 2025, 20:25 UTC

Utili

Transocean 2Q Loss $938M >RIG

4 ago 2025, 20:25 UTC

Utili

Transocean 2Q Loss/Shr $1.06 >RIG

4 ago 2025, 20:18 UTC

Utili

Palantir Stock Jumps. Earnings Blew Past Wall Street's Stratospheric Expectations. -- Barrons.com

4 ago 2025, 20:15 UTC

Utili

Vertex Pharma: Guidance Includes Immaterial Cost Impact From Tariffs in 2025 Based on Currently Known Tariff Rates and Regulations >VRTX

4 ago 2025, 20:14 UTC

Utili

Vertex Pharmaceuticals Reiterated FY25 Fincl Guidance >VRTX

4 ago 2025, 20:14 UTC

Utili

Vertex Pharma: Mark Bunnage, D.Phil., SVP of Global Research, to Assume Role of CSO Effective Feb 1, 2026 >VRTX

4 ago 2025, 20:14 UTC

Utili

Vertex Pharma: David Altshuler, Chief Scientific Officer, Intends to Retire Aug 1, 2026 >VRTX

4 ago 2025, 20:13 UTC

Utili

Vertex Pharmaceuticals Backs FY25 Rev $11.85B-$12B >VRTX

4 ago 2025, 20:09 UTC

Utili

Viper Energy: Initiating Avg Daily Production Guidance for 3Q of 46,000 to 49,000 Bo/d (86,000 to 92,000 Boe/d) >VNOM

4 ago 2025, 20:06 UTC

Utili

Palantir Earnings Blow Past Wall Street's Stratospheric Expectations -- Barrons.com

4 ago 2025, 20:01 UTC

Utili

Vertex Pharmaceuticals 2Q Net $1.03B >VRTX

4 ago 2025, 20:01 UTC

Utili

Vertex Pharmaceuticals 2Q Adj EPS $4.52 >VRTX

4 ago 2025, 20:01 UTC

Utili

Vertex Pharmaceuticals 2Q Rev $2.96B >VRTX

4 ago 2025, 20:01 UTC

Utili

Vertex Pharmaceuticals 2Q EPS $3.99 >VRTX

4 ago 2025, 19:41 UTC

Discorsi di Mercato

U.S. Natural Gas Futures Settle Lower -- Market Talk

4 ago 2025, 19:28 UTC

Discorsi di Mercato

U.S. Hiring Expected to Recover Once Uncertainty Dissipates -- Market Talk

4 ago 2025, 19:07 UTC

Discorsi di Mercato

Oil Extends Losing Streak As OPEC+ to Raise Output -- Market Talk

4 ago 2025, 18:27 UTC

Discorsi di Mercato

Gold Climbs on Rate Cut Speculation -- Market Talk

Confronto tra pari

Modifica del prezzo

Pluxee France SA Previsione

Obiettivo di Prezzo

By TipRanks

41.58% in crescita

Previsioni per 12 mesi

Media 24.48 EUR  41.58%

Alto 34 EUR

Basso 17.5 EUR

Basato su 9 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Pluxee France SA - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Neutrale

9 ratings

3

Acquista

5

Mantieni

1

Vendi

Notizie finanziarie

$